Arnon Kater
MD, PhD
Professor of Hematology
👥Biography 个人简介
Arnon Kater is a leading European CLL researcher who has pioneered fixed-duration venetoclax-ibrutinib combinations. His clinical trials through the HOVON network have demonstrated deep responses with time-limited therapy, reducing the need for continuous BTK inhibition. He has contributed to European guidelines on managing BTK inhibitor-resistant CLL.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Arnon Kater 的研究动态
Follow Arnon Kater's research updates
留下邮箱，当我们发布与 Arnon Kater（Amsterdam University Medical Centers）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment